EMPLIMET XR 10/5/1000MG TAB

EMPLIMET XR is a triple-action combination tablet containing Empagliflozin, Linagliptin, and Metformin. This extended-release formulation is designed to help manage type 2 diabetes by working through multiple mechanisms: improving insulin sensitivity, enhancing glucose excretion through the kidneys, and increasing incretin hormone activity. Each tablet delivers 10mg Empagliflozin, 5mg Linagliptin, and 1000mg Metformin for comprehensive glycemic control. Suitable for patients requiring multi-drug therapy to achieve target blood sugar levels. Take as directed by your healthcare provider.